Catalyst Pharmaceuticals, Inc.
CPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $163,889 | $71,410 | $83,079 | $39,482 |
| Dep. & Amort. | $37,774 | $32,881 | $1,239 | $192 |
| Deferred Tax | -$9,388 | -$17,818 | $4,937 | $9,316 |
| Stock-Based Comp. | $22,251 | $14,250 | $7,907 | $6,073 |
| Change in WC | $30,914 | -$37,324 | $13,729 | $5,022 |
| Other Non-Cash | -$5,632 | $80,201 | $5,156 | $287 |
| Operating Cash Flow | $239,808 | $143,600 | $116,047 | $60,372 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$556 | -$231 | -$29 | -$1,021 |
| Net Acquisitions | $0 | $0 | $10,000 | $0 |
| Inv. Purchases | $0 | -$13,465 | -$10,000 | -$10,000 |
| Inv. Sales/Matur. | $0 | $0 | $19,238 | $0 |
| Other Inv. Act. | $0 | -$279,806 | -$10,000 | $0 |
| Investing Cash Flow | -$556 | -$293,502 | $9,209 | -$11,021 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $141,000 | $0 | $0 | $0 |
| Stock Repurch. | -$296 | $0 | -$6,907 | -$12,089 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$39 | -$10,857 | $8,601 | $3,946 |
| Financing Cash Flow | $140,665 | -$10,857 | $1,694 | -$8,143 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $379,917 | -$160,759 | $126,950 | $41,208 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $137,636 | $298,395 | $171,445 | $130,237 |
| End Cash | $517,553 | $137,636 | $298,395 | $171,445 |
| Free Cash Flow | $239,252 | $61,856 | $116,018 | $59,351 |